Lab
Waynesboro Family Clinic
Waynesboro Family Clinic was paid $32.79M by Medicaid between Jan 2018 and Dec 2024, across 36 billing codes. Its largest line is H0040, Assertive community treatment program, per diem — 35% of everything it billed.
33Billing provider infoWAYNESBORO FAMILY CLINIC
GOLDSBORO, NC 27534
GOLDSBORO, NC 27534
33aNPI1760417570assigned 07/11/2006
33bProvider typeClinical Medical Laboratory
28Total paid$32.79M
24GClaims269,643
24DCodes billed36
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in North Carolina
Rank by total paid#10 of 128
Median peer was paid$268K
This provider vs. median122×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,620 | $3.13M | |
| 2019 | 34,389 | $3.34M | |
| 2020 | 38,356 | $4.93M | |
| 2021 | 41,851 | $5.48M | |
| 2022 | 38,966 | $5.23M | |
| 2023 | 38,379 | $4.80M | |
| 2024incomplete | 45,082 | $5.89M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| H0040 | Assertive community treatment program, per diem | 35% | 64,377 | 7,822 | $11.46M |
| H2015 | Community support for mental illness or disability, per 15 minutesComprehensive community support services, per 15 minutes | 21% | 33,481 | 3,793 | $6.82M |
| H0038 | Self-help/peer services, per 15 minutes | 14% | 30,706 | 4,889 | $4.60M |
| H2012 | Behavioral health day treatment, per hour | 6.5% | 12,784 | 793 | $2.14M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 6.3% | 28,744 | 18,888 | $2.06M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.5% | 32,921 | 26,647 | $1.48M |
| H2022 | Community-based wrap-around services, per diem | 3.6% | 4,569 | 434 | $1.17M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 9,114 | 7,273 | $594K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 1.7% | 3,211 | 2,742 | $573K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.2% | 3,986 | 3,462 | $386K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,793 | 3,932 | $316K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 4,075 | 2,779 | $216K |
24 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,636 | $174K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 3,818 | $126K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 1,335 | $114K |
| 96131 | <1% | 630 | $73K | |
| 96130 | <1% | 730 | $63K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,440 | $63K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 1,311 | $58K |
| 80061 | Lipid panel | <1% | 3,606 | $54K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 598 | $41K |
| 84439 | <1% | 3,757 | $37K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,330 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,270 | $29K |
| 84481 | <1% | 1,393 | $25K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,871 | $19K |
| 96101 | <1% | 122 | $17K | |
| 98966 | <1% | 1,238 | $15K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 321 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,070 | $10K |
| 98968 | <1% | 156 | $4K | |
| 98967 | <1% | 162 | $3K | |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 12 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 40 | $3K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 14 | $474.04 |
| 80050 | General health panel | <1% | 22 | $136.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVANNOSKE, NITA (CLINIC ADMINISTRATOR)